Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
UCB has kicked off BE BOLD, a Phase 3b head-to-head study comparing Bimzelx (bimekizumab) against Skyrizi (risankizumab, AbbVie) in adults with active psoriatic arthritis
10.1016/j.intimp.2024.113537 76 SinghA.SohalA.BattaA
It does not accept insurance for fees or medication
Keto Champ GLP-1 (Berry or Chocolate) Keto-friendly power fuel to keep you going strong
NAD Treatment in Pakistan: A New Frontier in Wellness For years, NAD+ IV Therapy was exclusively available in Western countries, unaffordable to the majority of people in Pakistan
US$ 28.87
US$ 28.46
US$ 24.32
